Canada’s ‘slow’ rollout of coronavirus vaccine ’embarrassing’: experts | Canada News Media
Connect with us

News

Canada’s ‘slow’ rollout of coronavirus vaccine ’embarrassing’: experts

Published

 on

A majority of Canadians should be vaccinated against the coronavirus by September 2021, according to Prime Minister Justin Trudeau. But with the current pace of the country’s vaccination distribution, experts warn provinces may not be able to reach the target anytime soon.

“Canada is definitely having a slower start,” said Kerry Bowman, a professor of bioethics and global health at the University of Toronto. “And each day and week goes by, we run the great risk of falling further and further behind.

Canada has fallen behind countries like Israel, the United States and the United Kingdom in vaccine distribution.

According to recent numbers from Our World In Data, a University of Oxford-based organization, the total number of vaccination doses administered per 100 people for Canada was 0.3, as of Jan. 2. For the U.S., it was 1.28, in the U.K. it was 1.39 (as of Dec. 27). And for Israel, it was 12.59.

Story continues below advertisement

Israel, which has vaccinated a higher proportion of its population against the coronavirus than any other country, is delivering shots so quickly it’s running out of vaccines.

Canada’s geography is, of course, much large than nations like the U.K. and Israel, meaning there are different logistical hurdles.

However, Bowman said geography still does not explain why the initial rollout has been so slow, as many administration sites are in large urban areas, such as Toronto, Montreal, and Vancouver.

These vaccines are of no use to anybody if they’re not in someone’s arm. … Having them in the country and in a freezer is not great.”

How many Canadians have been vaccinated?

Canada has so far approved two vaccines — by Pfizer-BioNTech (Dec. 9) and Moderna (Dec. 23). Both vaccines require two doses a number of weeks apart for full efficacy.

Provinces have differed in their approaches to the vaccine — some have held back supply to ensure a second dose is available when the time comes, while others planned to administer all doses as soon as they’re available.

Health Canada is also currently reviewing clinical data from Johnson and Johnson and AstraZeneca, so more vaccines are in the pipeline.

As of Sunday, Canada had administered 119,202 coronavirus vaccines across the country, according to COVID-19 Tracker Canada.

That means 0.317 per cent of the population has received at least one dose of a COVID-19 vaccine.

More than 420,000 doses of Moderna and Pfizer’s coronavirus vaccines have been delivered to the provinces for administration, according to the website. And as of Sunday, 28.4 per cent of the doses have been administered.

 

“It’s an utter failure when you have three-fourths of our vaccines still sitting inside of freezers,” said biostatistician Ryan Imgrund, who works with Ottawa Public Health.

In Ontario, Canada’s largest province, 42,419 people have been vaccinated since Dec. 14.

Imgrund called the number “embarrassingly” low.

“We have been hoping for this vaccine for quite some time and it’s still sitting inside of freezers. We’re still only vaccinating four (to five) thousand people per day (in Ontario). It’s a shame,” he said. “At 5,000 people per day, it would take eight years to vaccinate all of Ontario at this rate.”

Ontario, with a population of 14.57 million, previously said it expects to vaccinate approximately 8.5 million people by the end of June. So far, 19 hospitals across Ontario are equipped with administering the immunizations.

Why the slow start?

Imgrund said at first he believed the slow start was due to the storage requirements for Pfizer’s COVID-19 vaccine (which requires it to be stored at ultra-low temperatures of -70 C).

“But, now we now have the Moderna vaccine that can be easily rolled out, it can be stored in just basic freezers. We don’t need any specialty logistics for this to happen,” he said.

Bowman agreed.

He said the arrival of Moderna’s vaccine has helped speed up the rollout, but still, it’s not enough to meet the September target. And he said staffing and infrastructure are not to blame. It ultimately comes down to planning and leadership.

For example, Ontario paused coronavirus vaccinations during the Christmas holidays, citing staff shortages. Yet after the announcement, many health professionals took to social media saying they would volunteer their time.

We just haven’t had great planning on this,” he said. “I know health care professionals that volunteered weeks and even more than a month.

“Existing infrastructure is not being used and you have people volunteering that haven’t been called. And so that’s very, very worrisome,” Bowman said.

Like Bowman, Imgrund blamed the slow rollout in Ontario on a lack of leadership.

“I think that’s really what it comes down to because if you had a plan to actually get people vaccinated, you would run out of vaccines before you know. Instead, it’s the complete opposite … and it’s frustrating because we knew that in phase one we’re going to be targeting the most vulnerable people.

Global News reached out to the Canadian and Ontario governments for a comment about the vaccination rate but did not hear back by the time of publication.

Bowman and Imgrund argued that provinces should be asking family physicians, pharmacists and even veterinarians, to help get the vaccines in people’s arms.

The use of doctor’s offices, pharmacies and even high school gyms should also be utilized, they said.

“We don’t have schools open here in Ontario right now. Why not turn a local high school has a vaccination facility? And then bus long term care facility residents there,” Imgrund said.

On Monday, Manitoba became the first province to set up a “supersite” for vaccines, utilizing its convention centre to help inoculate frontline workers and vulnerable people.

Bowman said provinces like Ontario should follow suit and open up larger areas (on an appointment basis) to help administer more vaccines.

 

Source: – Global News

Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version